A femtosecond laser approach for eyes with low hyperopic presbyopia
Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.
Alcon’s Clareon PanOptix Pro IOL approved in Canada for cataract patients
Alcon's Clareon Panoptix Pro IOL enhances cataract surgery with advanced light utilization and low visual disturbance.
Clareon Panoptix Pro IOL (Alcon) approved in Canada
The trifocal IOL is designed to deliver lower light scatter and higher-reported light utilisation
Nationwide free transport for cataract patients through SpaMedica
SpaMedica to offer free transport for all NHS cataract patients, supporting community care and reducing health inequalities.
How a newly defined category of IOLs can benefit patient outcomes
A new functional classification can help achieve precise vision goals
Custom matching IOLs is key to managing patient satisfaction
Johann Krüger, MD, shares insights from 26 years of experience
Johnson & Johnson launches presbyopia-correcting Tecnis Odyssey IOL in Europe
The Tecnis Odyssey, launched in the US in October 2024, is now available in Europe, the Middle East and Canada